Evidence map›Paper›PMID 22114562›Full record

ArticlePLoS pathogens2011

Down-regulation of Shadoo in prion infections traces a pre-clinical event inversely related to PrP(Sc) accumulation.

David Westaway, Sacha Genovesi, Nathalie Daude, Rebecca Brown, Agnes Lau, Inyoul Lee, Charles E Mays, Janaky Coomaraswamy, Brenda Canine, Rose Pitstick and 8 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 41 citations in OpenAlex.

  1. The First Genetic Characterization of theAnimals : an open access journal from MDPI · 2024
    Article
  2. Article
  3. Article
  4. Quaternary Structure Changes for PrPMolecular neurobiology · 2021
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Knockout of the prion protein (PrP)-like Sprn gene does not produce embryonic lethality in combination with PrP(C)-deficiency.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 6 institutions in 3 countries.

David WestawayCentre for Prions and Protein Folding Diseases, University of Alberta, Edmonton, Alberta, Canada.
Sacha Genovesi
Nathalie Daude
Rebecca Brown
Agnes Lau
Inyoul Lee
Charles E Mays
Janaky Coomaraswamy
Brenda Canine
Rose Pitstick
Allen Herbst
Jing Yang
Kerry W S Ko
Gerold Schmitt-Ulms
Stephen J Dearmond
Debbie McKenzie
Leroy Hood
George A Carlson
University of Alberta · CAMcLaughlin Research Institute · USUniversity of Washington · USHertie Institute for Clinical Brain Research · DEOccupational Cancer Research Centre · CAUniversity of California, San Francisco · US

Funding

TRANSGENETICS OF CHIMERIC PROTEINS IN PRION REPLICATION &DISEASEP01NS041997 · NINDS · MC LAUGHLIN RESEARCH INSTITUTE · PI DEARMOND, STEPHEN J. · 2001 to 2011
$15.0M
CIHR MOP36377Medical Research Council MC_G1000734NINDS NIH HHS NS41997NINDS NIH HHS P01 NS041997Wellcome Trust 089703
6 · The paper itself

Abstract

During prion infections of the central nervous system (CNS) the cellular prion protein, PrP(C), is templated to a conformationally distinct form, PrP(Sc). Recent studies have demonstrated that the Sprn gene encodes a GPI-linked glycoprotein Shadoo (Sho), which localizes to a similar membrane environment as PrP(C) and is reduced in the brains of rodents with terminal prion disease. Here, analyses of prion-infected mice revealed that down-regulation of Sho protein was not related to Sprn mRNA abundance at any stage in prion infection. Down-regulation was robust upon propagation of a variety of prion strains in Prnp(a) and Prnp(b) mice, with the exception of the mouse-adapted BSE strain 301 V. In addition, Sho encoded by a TgSprn transgene was down-regulated to the same extent as endogenous Sho. Reduced Sho levels were not seen in a tauopathy, in chemically induced spongiform degeneration or in transgenic mice expressing the extracellular ADan amyloid peptide of familial Danish dementia. Insofar as prion-infected Prnp hemizygous mice exhibited accumulation of PrP(Sc) and down-regulation of Sho hundreds of days prior to onset of neurologic symptoms, Sho depletion can be excluded as an important trigger for clinical disease or as a simple consequence of neuronal damage. These studies instead define a disease-specific effect, and we hypothesize that membrane-associated Sho comprises a bystander substrate for processes degrading PrP(Sc). Thus, while protease-resistant PrP detected by in vitro digestion allows post mortem diagnosis, decreased levels of endogenous Sho may trace an early response to PrP(Sc) accumulation that operates in the CNS in vivo. This cellular response may offer new insights into the homeostatic mechanisms involved in detection and clearance of the misfolded proteins that drive prion disease pathogenesis.

Indexed as

AnimalsBrainDown-RegulationGPI-Linked ProteinsMiceMice, TransgenicNerve Tissue ProteinsPrion DiseasesPrPC ProteinsPrPSc ProteinsRNA, MessengerGPI-Linked ProteinsNerve Tissue ProteinsPrPC ProteinsPrPSc ProteinsRNA, MessengerSprn protein, mouse

Identifiers

PMID22114562
PMCPMC3219720
OpenAlexW1989531230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.